Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,944.00    21.00 (1.09%)
Bid:
1,930.00
Ask:
1,937.00
Spread: 7.00 (0.363%)
Market Cap: £2.17b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Annual Financial Report

14 Apr 2026 11:14

RNS Number : 4229A
Derwent London PLC
14 April 2026
 

For immediate release

 

 

Derwent London plc ("Derwent London" / "the Group")  Notice of the 2026 Annual General Meeting ("AGM") andpublication of the 2025 Report & Accounts and the 2025 Responsibility Report

 

Notice of 2026 AGM and 2025 Report & Accounts

Derwent London announces that copies of the Notice of the 2026 AGM and 2025 Report & Accounts have been made available to shareholders and can be viewed and downloaded on the Group's website www.derwentlondon.com

 

Copies of these documents, together with the Form of Proxy for the AGM, will be submitted to the National Storage Mechanism (via the Electronic Submission System) shortly.

 

In accordance with Rule 4.1.15R of the Disclosure and Transparency Rules, the Group has published its 2025 Report & Accounts in Extensible Hypertext Markup Language (XHTML) and key elements of its financial statements have been 'tagged' using Extensible Business Reporting Language (XBRL) markup language. This version of the 2025 Report & Accounts will also be submitted to the National Storage Mechanism and is available on our website.

 

In accordance with Rule 4.1.3R of the Disclosure and Transparency Rules, the Group published its annual results for the year ended 31 December 2025 on 26 February 2026.

 

2026 AGM

As set out in the Notice of the 2026 AGM, the Group's 42nd AGM will be held on 15 May 2026 at 9:30 am. The Directors look forward to meeting with shareholders in person.

 

It would be helpful to the smooth running of the AGM if questions could be submitted to the Company Secretary, David Lawler, at company.secretary@derwentlondon.com, up to one day before the commencement of the AGM.

 

2025 Responsibility Report

The 2025 Responsibility Report, and associated Data Report workbook, have also been published today and are available to be viewed at www.derwentlondon.com/responsibility/publications

 

 

Enquiries:

D A Lawler

Company Secretary

14 April 2026

 

020 7659 3000

www.derwentlondon.com

 

Notes to editors 

 

Derwent London plc

 

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.1 billion as at 31 December 2025, making it the largest London office-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

 

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, with its updated pathway published in 2025. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 200 community projects in central London.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSUSARRNRUSAAR
Date   Source Headline
25th Apr 20194:04 pmRNSHolding(s) in Company
23rd Apr 20199:00 amRNSBondholders' meeting
15th Apr 20191:00 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
5th Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20193:00 pmRNSDirector Declaration
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.